CareLit Fachartikel

Wissenschaftliche Stellungnahme: Norethisteronacetat (NETA) - eine Risikosubstanz?

H. Kuhl · Geburtshilfe und Frauenheilkunde · 2000 · Heft 08 · S. 393-406

Dokument
1006452
CareLit-ID
Jahr
2000
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Geburtshilfe und Frauenheilkunde
Autor:innen
H. Kuhl
Ausgabe
Heft 08 / 2000
Jahrgang 60
Seiten
393-406
Erschienen: 2000-01-01 00:00:00
ISSN
0016-5751

Zusammenfassung

Summary For many years, breast cancer has been a main issue in the discussions concerning the effects of natural and synthetic steroids. Numerous theories and hypotheses on the etiology of breast cancer have been advanced and rejected. During the last years the discussion has gained intensity. Based on in vitro-investigations with breast cancer cell lines which revealed an inhibitory effect of progestogens on proliferation when continuously present, it was assumed that continuous combined hormone replacement therapy (HRT) protects against breast cancer [, ]. The available epidemiological data, however, failed to…

Schlagworte

Geburtshilfe und Frauenheilkunde